Suboptimal control and failure to intensify therapy for South Africans with type 2 diabetes: an audit of diabetes management at primary health care facilities

References

• Boake M, Mash R. Diabetes in the Western Cape, South Africa: a secondary analysis of the diabetes cascade database 2015–2020. Prim Care Diabetes. 2022;16(4):555–61. https://doi.org/10.1016/j.pcd.2022.05.011
   PubMed Web of Science ®Google Scholar
• International Diabetes Federation. IDF diabetes Atlas. 10th ed Brussels: Belgium; 2021.
   Google Scholar
• UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837–53. https://doi.org/10.1016/S0140-6736(98)07019-6
   PubMed Web of Science ®Google Scholar
• Chun J, Strong J, Urquhart S. Insulin initiation and titration in patients with type 2 diabetes. Diabetes Spectr. 2019;32(2):104–11. https://doi.org/10.2337/ds18-0005
   PubMedGoogle Scholar
• Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American diabetes association and the European association for the study of diabetes. Diabetes Care. 2015;38(1):140–9. https://doi.org/10.2337/dc14-2441
   PubMed Web of Science ®Google Scholar
• Lee M-K. Blood glucose control: where are we? J Diabetes Investig. 2021;12(10):1762–4. https://doi.org/10.1111/jdi.13632
   PubMed Web of Science ®Google Scholar
• Reach G, Pechtner V, Gentilella R, et al. Clinical inertia and its impact on treatment intensification in people with type 2 diabetes mellitus. Diabetes Metab. 2017;43(6):501–11. https://doi.org/10.1016/j.diabet.2017.06.003
   PubMed Web of Science ®Google Scholar
• Schmieder RE, Tschöpe D, Koch C, et al. Individualised treatment targets in patients with type-2 diabetes and hypertension. Cardiovasc Diabetol. 2018;17(1):1–11. https://doi.org/10.1186/s12933-018-0661-8
   PubMedGoogle Scholar
• Phillips LS, Branch Jr WT, Cook CB, et al. Clinical inertia. Ann Intern Med. 2001;135(9):825–34. https://doi.org/10.7326/0003-4819-135-9-200111060-00012
   PubMed Web of Science ®Google Scholar
• Khunti K, Wolden ML, Thorsted BL, et al. Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people. Diabetes Care. 2013;36(11):3411–7. https://doi.org/10.2337/dc13-0331
   PubMed Web of Science ®Google Scholar
• The Society for Endocrinology, Metabolism and Diabetes of South Africa Type 2 Diabetes Guidelines Expert Committee. The 2017 Semdsa guidelines for the management of type 2 diabetes. J Endocrinol, Metab Diabetes S Afr. 2017;22(Number 1 (Supplement 1)):S1–S196.
   Google Scholar
• Pinchevsky Y, Butkow N, Chirwa T, et al. Treatment gaps found in the management of type 2 diabetes at a community health centre in Johannesburg, South Africa. J Diabetes Res. 2017;2017:1–6. https://doi.org/10.1155/2017/9536025
   Web of Science ®Google Scholar
• Webb EM, Rheeder P, Van Zyl DG. Diabetes care and complications in primary care in the Tshwane district of South Africa. Prim Care Diabetes. 2015;9(2):147–54. https://doi.org/10.1016/j.pcd.2014.05.002
   PubMed Web of Science ®Google Scholar
• Bak JCG, Serné EH, Kramer MHH, et al. National diabetes registries: do they make a difference? Acta Diabetol. 2021;58(3):267–78. https://doi.org/10.1007/s00592-020-01576-8
   PubMed Web of Science ®Google Scholar
• Essential Drugs Programme. Republic of South Africa. Primary healthcare standard treatment guidelines and essential medicines list. 6th ed Pretoria: National Department of Health; 2018.
   Google Scholar
• Kalain A, Omole OB. Lifestyle advice, processes of care and glycaemic control amongst patients with type 2 diabetes in a South African primary care facility. Afr J Prim Health Care Fam Med. 2020;12(1):1–6. https://doi.org/10.4102/phcfm.v12i1.2163
   Web of Science ®Google Scholar
• Sonday F, Bheekie A, van Huyssteen M. Pharmacist-led medication therapy management of diabetes club patients at a primary healthcare clinic in Cape Town, South Africa: a retrospective and prospective audit. S Afr Med J. 2022;112(6):437–45.https://doi.org/10.7196/SAMJ.2022.v112i6.16247
   PubMed Web of Science ®Google Scholar
• LeRoith D. Hyperglycemia, hypertension, and dyslipidemia in type 2 diabetes mellitus: goals for diabetes management. Clin Cornerstone. 2008;9:S8–S16. https://doi.org/10.1016/S1098-3597(09)60021-1
   PubMedGoogle Scholar
• Rampersad K, Rangiah S, Kendon M. Compliance with local diabetic guidelines at a district hospital in KwaZulu-Natal, South Africa. S Afr Family Pract. 2019;61(2):60–4. https://doi.org/10.1080/20786190.2018.1507565
   Web of Science ®Google Scholar
• Govender RD, Gathiram P, Panajatovic M. Poor control and management of type 2 diabetes mellitus at an under-resourced South African hospital: is it a case of clinical inertia? S Afr Family Pract. 2017;59(5):154–9. https://doi.org/10.1080/20786190.2017.1307909
   Web of Science ®Google Scholar
• Murphy K, Chuma T, Mathews C, et al. A qualitative study of the experiences of care and motivation for effective self-management among diabetic and hypertensive patients attending public sector primary health care services in South Africa. BMC Health Serv Res. 2015;15(1):303. https://doi.org/10.1186/s12913-015-0969-y
   PubMedGoogle Scholar
• Hayat SA, Patel B, Khattar RS, et al. Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clin Sci. 2004;107(6):539–57. https://doi.org/10.1042/CS20040057
   PubMed Web of Science ®Google Scholar
• Naidoo S, Raal F. Pattern of dyslipidaemia in relation to statin use in patients with type 2 diabetes mellitus attending a tertiary care hospital. J Endocrinol, Metab Diabetes S Afr. 2019: 1–6. https://doi.org/10.1080/16089677.2019.1686869
   Web of Science ®Google Scholar
• Owolabi EO, Goon DT, Ajayi AI, et al. Coverage of diabetes complications screening in rural Eastern Cape, South Africa: a cross-sectional survey. S Afr Family Pract. 2022;64(1):e1–e6. https://doi.org/10.4102/safp.v64i1.5447
   Web of Science ®Google Scholar
• Kalweit KL, Van Zyl DG, Rheeder P. Titrating insulin in patients with type 2 diabetes using a structured self-monitoring blood glucose regimen. S Afr Med J. 2018;108(8):654–9. https://doi.org/10.7196/SAMJ.2018.v108i8.12801
   PubMed Web of Science ®Google Scholar
• Webb EM, Rheeder P. A cluster-randomized trial to estimate the effect of mobile screening and treatment feedback on HbA1c and diabetes-related complications in tshwane primary health care clinics, South Africa. Prim Care Diabetes. 2017;11(6):546–54. https://doi.org/10.1016/j.pcd.2017.05.010
   PubMed Web of Science ®Google Scholar
• Mayet L, Naidoo SS. An evaluation of insulin therapy initiation among patients with type 2 diabetes attending a public health facility in South Africa. S Afr Family Pract. 2012;54(6):525–30. https://doi.org/10.1080/20786204.2012.10874287
   Google Scholar
• Ngassa Piotie P, Muchiri JW, Webb EM, et al. Assessing barriers to insulin therapy among people with type 2 diabetes in South Africa using the insulin treatment appraisal scale: a cross-sectional survey. Prim Care Diabetes. 2022;16(4):509–14. https://doi.org/10.1016/j.pcd.2022.05.012
   PubMed Web of Science ®Google Scholar
• Ngassa Piotie P, Wood P, Webb EM, et al. Willingness of people with type 2 diabetes to start insulin therapy: evidence from the South African Tshwane Insulin Project (TIP). Diabetes Res Clin Pract. 2020;168:108366. https://doi.org/10.1016/j.diabres.2020.108366
   PubMed Web of Science ®Google Scholar
• Okemah J, Peng J, Quiñones M. Addressing clinical inertia in type 2 diabetes mellitus: a review. Adv Ther. 2018;35(11):1735–45. https://doi.org/10.1007/s12325-018-0819-5
   PubMed Web of Science ®Google Scholar